Bioheart (BHRT) Board Appoints Howard J. Leonhardt CEO
More News related to BHRT
- Bioheart Elects Lee Jones to Its Board of Directors
- Bioheart Makes Breakthrough in Cardiovascular Therapy with Stem Cells Obtained from Fat Tissue
- Bioheart Partners (BHRT) With Life Technologies (LIFE) to Offer Myoblast Cell Products to the Research Market
- Bioheart (BHRT) Announces CE Marking for TGI 1200(tm) Adult Stem Cell Isolation System
- Bioheart (BHRT) Board Appoints Howard J. Leonhardt CEO
Bioheart (Nasdaq: BHRT) announced that its Board of Directors appointed Howard J. Leonhardt, Bioheart's co-founder, Chairman of the Board and Chief Technology Officer, to serve as Chief Executive Officer effective as of July 1, 2008. This follows the resignation of William M. Pinon as the Company's President and CEO and as a member of the Board of Directors as of the same date. Pinon has agreed to remain with the Company through July 25, 2008 to assist in the executive transition process.
Bioheart is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.
Related Categories
Management ChangesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
